Items where Author is "Thomas, Alan J."
Number of items: 5.
Cost-effectiveness of mirtazapine for agitated behaviors in dementia:findings from a randomized controlled trial. (2022)
Henderson, Catherine and Knapp, Martin and Stirling, Susan and Shepstone, Lee and High, Juliet and Ballard, Clive and Bentham, Peter and Burns, Alistair and Farina, Nicolas and Fox, Chris and Fountain, Julia and Francis, Paul and Howard, Robert and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O’brien, John T. and Price, Annabel and Swart, Ann Marie and Tabet, Naji and Telling, Tanya and Thomas, Alan J. and Banerjee, Sube
picture_as_pdf
Long-term impact of the COVID-19 pandemic on the quality of life of people with dementia and their family carers.
Read, Sanna and Hicks, Ben and Budden, Emily and Douglass, Jacob and Grahamslaw, Amanda and Herrero, Elena and Joseph, Gregory and Kirkup, Christine and Pusey, Martha and Russell, Alice and Sondh, Harsharon K. and Sondh, Sharon and Storey, Bryony and Towson, Georgia and Baxter, Kate and Birks, Yvonne and Brayne, Carol and Colclough, Carmen and Dangoor, Margaret and Dixon, Josie and Donaghy, Paul and Gridley, Kate and Harris, Peter R. and Hu, Bo and King, Derek and Knapp, Martin and Miles, Eleanor and Mueller, Christoph and Perach, Rotem and Robinson, Louise and Rusted, Jennifer M. and Thomas, Alan J. and Wittenberg, Raphael and Banerjee, Sube
picture_as_pdf
Study of mirtazapine for agitated behaviours in dementia (SYMBAD):a randomised, double-blind, placebo-controlled trial.
Banerjee, Sube and High, Juliet and Stirling, Susan and Shepstone, Lee and Swart, Ann Marie and Telling, Tanya and Henderson, Catherine and Ballard, Clive and Bentham, Peter and Burns, Alistair and Farina, Nicolas and Fox, Chris and Francis, Paul and Howard, Robert and Knapp, Martin and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O'Brien, John and Price, Annabel and Thomas, Alan J. and Tabet, Naji
picture_as_pdf
A cohort study of the impact of COVID-19 on the quality of life of people newly diagnosed with dementia and their family carers.
Hicks, Ben and Read, Sanna and Hu, Bo and Wittenberg, Raphael and Grahamslaw, Amanda and Karim, Anomita and Martin, Evelyn and Nuzum, Eleanor and Reichental, Jacob and Russell, Alice and Siddle, Elaine and Storey, Bryony and Tipping, Eva and Baxter, Kate and Birks, Yvonne and Brayne, Carol and Brimblecombe, Nicola and Dangoor, Margaret and Dixon, Josie and Gridley, Kate and Harris, Peter R. and Knapp, Martin and Miles, Eleanor and Perach, Rotem and Robinson, Louise and Rusted, Jennifer and Stewart, Rob and Thomas, Alan J. and Banerjee, Sube
picture_as_pdf
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours:the HTA-SYMBAD trial.
Banerjee, Sube and Farina, Nicolas and Henderson, Catherine and High, Juliet and Stirling, Susan and Shepstone, Lee and Fountain, Julia and Ballard, Clive and Bentham, Peter and Burns, Alistair and Fox, Chris and Francis, Paul and Howard, Robert and Knapp, Martin and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O’Brien, John and Price, Annabel and Thomas, Alan J. and Swart, Ann Marie and Telling, Tanya and Tabet, Naji
picture_as_pdf